CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Sep. 27, 2024	Sep. 29, 2023
Cash flows from operating activities:
Net (loss) income	$ (51,226)	$ 126,560
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	32,455	29,353
Amortization of deferred financing costs	1,087	107
Deferred income taxes	(7,795)	(18,134)
Stock-based compensation	21,663	21,919
Loss on change in fair value of forward repurchase contract	34,752	0
Provisions for inventory and expected credit losses	4,488	9,422
Change in fair value of marketable securities	0	3,579
Other non-cash reconciling items	6,577	43
Changes in operating assets and liabilities:
Trade accounts receivable	41,417	(7,645)
Inventories	(18,831)	(31,221)
Prepaid expenses and other assets	(15,808)	(16,453)
Trade accounts payable	13,670	2,695
Due to and from related parties	4,132	6,112
Accrued expenses and other current and long-term liabilities	(16,838)	(29,944)
Net cash provided by operating activities	49,743	96,393
Cash flows from investing activities:
Purchases of property, plant and equipment	(20,949)	(76,101)
Sales of marketable securities	0	16,175
Net cash used in investing activities	(20,949)	(59,926)
Cash flow from financing activities:
Loan made to affiliate	0	(4,000)
Finance lease payments	(385)	0
Receipts on related party notes receivable	1,875	1,875
Payments for taxes related to net share settlement of equity awards	(12,297)	(14,091)
Proceeds from issuance of common stock under employee stock purchase plan	1,987	1,899
Repurchases of common stock	(853,805)	0
Net proceeds from issuance of common stock	665,850	0
Payments of debt issuance costs	0	(1,450)
Net cash used in financing activities	(53,292)	(15,767)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	1,375	(974)
Net (decrease) increase in cash and cash equivalents and restricted cash	(23,123)	19,726
Cash and cash equivalents and restricted cash at beginning of period	222,161	358,705
Cash and cash equivalents and restricted cash at end of period:	199,038	378,431
2023 Term Loan Facility
Cash flow from financing activities:
Net proceeds from Refinanced 2023 Term Loan Facility	193,483	0
Payment of borrowings under 2023 Term Loan Facility	$ (50,000)	$ 0